BDBM511720 US11084800, Cpd No. 25::US11708351, Compound 25::methyl 3-acetyl-1-(2-((2S,4R)-2-((6- bromopyridin-2-yl)carbamoyl)-4- fluoropyrrolidin-1-yl)-2-oxoethyl)-5-(2- methylpyrimidin-5-yl)-1H-indazole-7- carboxylate

SMILES COC(=O)c1cc(cc2c(nn(CC(=O)N3C[C@H](F)C[C@H]3C(=O)Nc3cccc(Br)n3)c12)C(C)=O)-c1cnc(C)nc1

InChI Key InChIKey=XDKBRTFTHDCPBN-NQIIRXRSSA-N

Data  2 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 511720   

TargetComplement factor D(Homo sapiens (Human))
Achillion Pharmaceuticals

US Patent
LigandPNGBDBM511720(US11084800, Cpd No. 25 | US11708351, Compound 25 |...)
Affinity DataIC50: <1.00E+3nMAssay Description:Human Factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration is incubated with test compound at various conce...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetComplement factor D(Homo sapiens (Human))
Achillion Pharmaceuticals

US Patent
LigandPNGBDBM511720(US11084800, Cpd No. 25 | US11708351, Compound 25 |...)
Affinity DataIC50: <1.00E+3nMAssay Description:Human Factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration is incubated with test compound at various conce...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent